France - Germany - North America - Switzerland
OCTOBER 21-22, 2020 Market access strategy for HealthTech start-ups
Image Image Image Image Image Image Image Image Image Image Image Image

Get in touch with Corporates, Manufacturers, and investors

Organized by SEMIA and the trinational life sciences & innovation ecosystem, the ‘Trinational HealthTech Days #1’ business event aims to connect innovative startups and the ecosystems from Germany, Switzerland, North America and France and to promote international cooperation in the health technology sector (biotech, medtech, digital health) with a dual challenge:

  • a better understanding of market specificities in order to strengthen the market access strategy for startups
  • the opportunity to network with nearby startups and connect with funds, VCs and corporate investors

PROGRAM

21 October - Day 1

EU market access strategy for health products and country particularities

OPENING PLENARY SESSIONS: 13:45 – 14:30

13:45 – 14:00   

Opening remarks

 Speakers:

Pascal Neuville, CEO Domain Therapeutics, President SEMIA

Bodo Brückner, Coordinator Lifescience Accelerator Baden-Wuerttemberg

Thomas Scheuerle, Managing Director bei BadenCampus
Guillaume Vetter-Genoud, Head of deeptech/healthcare, SEMIA
Douglas Haggstrom, Manager DayOne Accelerator bei Basel Area Business & Innovation

14:00 – 14:30

Basics of EU Market access strategy for health products and main challenges
Speaker:

Eric Rambeaux, Founder & CEO, Corporate Development expert, e4e6 Consulting

THEMATIC WORKSHOP SESSIONS (optional): 14:30 – 16:00

14:30 – 16:00

Market access specificities in France, Germany and Switzerland for medtech products (medtech session)

Moderator: Eric Rambeaux

Speakers:

Sylvia Germain, Founder & CEO, SGE-Consulting (France)

Isabelle FAU, Director of Economic Affairs and Market access, SGE-Consulting (France)

Alexis Hagenstein, Market Access Manager, Biomedical Engineer, SGE Consulting (France)

Guillaume Gerard, Founder, SEA Pharmaceuticals Gmbh (Switzerland)

Tobias Gantner, MD, PhD, MBA, LLM, Founder & CEO, former Head Market Access Bayer Germany, HealthCare Futurists GmbH, Cologne / PhilonMed GmbH, Heidelberg (Germany)

Dr.Jörg Hauffe, Project Manager, Senior Consultant Clinical & Regulatory Affairs, Seleon GmbH (Germany)

14:30 – 15:30

Journey and challenges from science to choice of indication and target product profile (biotech session)

Moderator: Zaki Sellam

Speakers:

Shahin Gharakhanian

Marie Petit 

Emmanuel Grillot 

CEO TESTIMONIALS/STORIES (optional): 16:00 – 17:00

16:00 – 17:00

CEO Testimonials/Stories (medtech session)

Moderator: Eric Rambeaux

Speakers: 

Malaika Lauk, CEO Lauk Ventures GmbH

Philippe Bastide, CEO Dianosic

Edouard Fonck, CEO VeoSource

22 October - Day 2

Startups & Investors/Corporates meetings & trinational networking

13:45 – 14:00

Opening remarks

14:00 – 17:00

Startups & Investors/Corporates One-on-One meetings

14:00 – 15:00

Business Angel Investing: why diversity of gender & skills is key?

Why investors are changing the lens they use to view startups before making their investment decisions. How to increase the chances of success and long term sustainability of your startup.

Moderator: Maarten Van Winckel 

Speaker: Trudi Haemmerli 

SPEAKERS

Image
Eric Rambeaux

Founder & CEO, Corporate Development expert, e4e6 Consulting.       
Image
Sylvia Germain

Founder & CEO, SGE-Consulting (France).Lo                                                                 rem ipsum dolor sit r ali.              
Image
Isabelle FAU

Director of Economic Affairs and Market access, SGE-Consulting                     
Image
Alexis Hagenstein

Market Access Manager, Biomedical Engineer, SGE Consulting                           
Image
Guillaume Gerard

Founder, SEA Pharmaceuticals GmbH - expertise in Pharma/Biotech and Medtech industry close to 20 years ago experience from technical development to general management.
Image
Tobias Gantner

MD, PhD, MBA, LLM, Founder & CEO, former Head Market Access Bayer Germany, HealthCare Futurists GmbH, Cologne / PhilonMed GmbH, Heidelberg (Germany) 
Image
Dr.Jörg Hauffe

Project Manager, Senior Consultant Clinical & Regulatory Affairs, Seleon GmbH (Germany)                                                                                                                                   
Image
Zaki Sellam

C-Level Biotech Executive & Corporate Strategy Advisor.                             
Image
Shahin Gharakhanian

                                                                                                                                                       
Image
Marie Petit

                                                                                                                                                               
Image
Emmanuel Grillot

Founder & Chief Executive, Baehl Innovation                                                      
Image
Pascal Neuville

CEO Domain Therapeutics, President SEMIA                                                      
Image
Stéphane Chauffriat

CEO, SEMIA
Organization committee

Bodo Brückner, Coordinator Lifescience Accelerator Baden-Wuerttemberg

Markus Buehler, Startup Support Manager, LSA, Technologie park Heidelberg

Leonildo Delgado, Manager innovation at Baselaunch

Guillaume Facchi, Strategic Program Manager at BioValley France

Yves Gendrault, Public research project manager, SEMIA/SATT Conectus

Douglas Haggstrom, Manager Day One Accelerator, Basel Area Business and innovation

Romain Neidl, Healthcare Business manager, SEMIA

Thomas Scheuerle, Managing Director bei BadenCampus

Kirsten Sink, Consultant Innovationsmanagement und Start-up-Förderung, BadenCampus

Katerina Tsouroula, Digital health Business manager, SEMIA

Maarten Van Winckel, Startup Community & Initiatives at University of Basel

Guillaume Vetter-Genoud, Head of deeptech/healthcare, SEMIA

Corporates
 
 
 
 

Venture capital

Business Angels

KIC
 

They support us